Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD.

Furer V, Rondaan C, Heijstek M, van Assen S, Bijl M, Agmon-Levin N, Breedveld FC, D'Amelio R, Dougados M, Kapetanovic MC, van Laar JM, Ladefoged de Thurah A, Landewé R, Molto A, Müller-Ladner U, Schreiber K, Smolar L, Walker J, Warnatz K, Wulffraat NM, Elkayam O.

RMD Open. 2019 Sep 19;5(2):e001041. doi: 10.1136/rmdopen-2019-001041. eCollection 2019.

2.

Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations.

Rondaan C, Furer V, Heijstek MW, Agmon-Levin N, Bijl M, Breedveld FC, D'Amelio R, Dougados M, Kapetanovic MC, van Laar JM, Ladefoged de Thurah A, Landewé R, Molto A, Müller-Ladner U, Schreiber K, Smolar L, Walker J, Warnatz K, Wulffraat NM, van Assen S, Elkayam O.

RMD Open. 2019 Sep 9;5(2):e001035. doi: 10.1136/rmdopen-2019-001035. eCollection 2019.

3.

2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases.

Furer V, Rondaan C, Heijstek MW, Agmon-Levin N, van Assen S, Bijl M, Breedveld FC, D'Amelio R, Dougados M, Kapetanovic MC, van Laar JM, de Thurah A, Landewé RB, Molto A, Müller-Ladner U, Schreiber K, Smolar L, Walker J, Warnatz K, Wulffraat NM, Elkayam O.

Ann Rheum Dis. 2020 Jan;79(1):39-52. doi: 10.1136/annrheumdis-2019-215882. Epub 2019 Aug 14.

PMID:
31413005
4.

Sonication of heart valves detects more bacteria in infective endocarditis.

Gomes A, van Oosten M, Bijker KLB, Boiten KE, Salomon EN, Rosema S, Rossen JWA, Natour E, Douglas YL, Kampinga GA, van Assen S, Sinha B.

Sci Rep. 2018 Aug 28;8(1):12967. doi: 10.1038/s41598-018-31029-w.

5.

Increased incidence of herpes zoster in patients on renal replacement therapy cannot be explained by intrinsic defects of cellular or humoral immunity to varicella-zoster virus.

Rondaan C, de Joode AAE, van Assen S, Bos NA, Westerhuis R, Westra J.

Antiviral Res. 2018 Oct;158:206-212. doi: 10.1016/j.antiviral.2018.08.006. Epub 2018 Aug 10.

PMID:
30102958
6.

Imaging infective endocarditis: Adherence to a diagnostic flowchart and direct comparison of imaging techniques.

Gomes A, van Geel PP, Santing M, Prakken NHJ, Ruis ML, van Assen S, Slart RHJA, Sinha B, Glaudemans AWJM.

J Nucl Cardiol. 2018 Jul 31. doi: 10.1007/s12350-018-1383-8. [Epub ahead of print]

PMID:
30066279
7.

Improving the Diagnostic Performance of 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography in Prosthetic Heart Valve Endocarditis.

Swart LE, Gomes A, Scholtens AM, Sinha B, Tanis W, Lam MGEH, van der Vlugt MJ, Streukens SAF, Aarntzen EHJG, Bucerius J, van Assen S, Bleeker-Rovers CP, van Geel PP, Krestin GP, van Melle JP, Roos-Hesselink JW, Slart RHJA, Glaudemans AWJM, Budde RPJ.

Circulation. 2018 Oct 2;138(14):1412-1427. doi: 10.1161/CIRCULATIONAHA.118.035032.

PMID:
30018167
8.

A standardized approach to treat complex aortic valve endocarditis: a case series.

Gomes A, Jainandunsing JS, van Assen S, van Geel PP, Sinha B, Gelsomino S, Johnson DM, Natour E.

J Cardiothorac Surg. 2018 Apr 19;13(1):32. doi: 10.1186/s13019-018-0715-8.

9.

Longitudinal analysis of varicella-zoster virus-specific antibodies in systemic lupus erythematosus: No association with subclinical viral reactivations or lupus disease activity.

Rondaan C, van Leer CC, van Assen S, Bootsma H, de Leeuw K, Arends S, Bos NA, Westra J.

Lupus. 2018 Jul;27(8):1271-1278. doi: 10.1177/0961203318770535. Epub 2018 Apr 18.

10.

Yield of yearly routine physical examination in HIV-1 infected patients is limited: A retrospective cohort study in the Netherlands.

van Amsterdam MA, van Assen S, Sprenger HG, Wilting KR, Stienstra Y, Bierman WFW.

PLoS One. 2017 Jun 21;12(6):e0179539. doi: 10.1371/journal.pone.0179539. eCollection 2017.

11.

Efficacy of Antibiotic Suppressive Therapy in Patients with a Prosthetic Joint Infection.

Wouthuyzen-Bakker M, Nijman JM, Kampinga GA, van Assen S, Jutte PC.

J Bone Jt Infect. 2017 Jan 15;2(2):77-83. doi: 10.7150/jbji.17353. eCollection 2017.

12.

Diagnostic value of imaging in infective endocarditis: a systematic review.

Gomes A, Glaudemans AWJM, Touw DJ, van Melle JP, Willems TP, Maass AH, Natour E, Prakken NHJ, Borra RJH, van Geel PP, Slart RHJA, van Assen S, Sinha B.

Lancet Infect Dis. 2017 Jan;17(1):e1-e14. doi: 10.1016/S1473-3099(16)30141-4. Epub 2016 Oct 18. Review.

PMID:
27746163
13.

Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative.

Baillet A, Gossec L, Carmona L, Wit Md, van Eijk-Hustings Y, Bertheussen H, Alison K, Toft M, Kouloumas M, Ferreira RJ, Oliver S, Rubbert-Roth A, van Assen S, Dixon WG, Finckh A, Zink A, Kremer J, Kvien TK, Nurmohamed M, van der Heijde D, Dougados M.

Ann Rheum Dis. 2016 Jun;75(6):965-73. doi: 10.1136/annrheumdis-2016-209233. Epub 2016 Mar 16. Review.

14.

Management of renal cyst infection in patients with autosomal dominant polycystic kidney disease: a systematic review.

Lantinga MA, Casteleijn NF, Geudens A, de Sévaux RG, van Assen S, Leliveld AM, Gansevoort RT, Drenth JP; DIPAK Consortium.

Nephrol Dial Transplant. 2017 Jan 1;32(1):144-150. doi: 10.1093/ndt/gfv452. Review.

PMID:
26908766
15.

An integrated stewardship model: antimicrobial, infection prevention and diagnostic (AID).

Dik JW, Poelman R, Friedrich AW, Panday PN, Lo-Ten-Foe JR, van Assen S, van Gemert-Pijnen JE, Niesters HG, Hendrix R, Sinha B.

Future Microbiol. 2016;11(1):93-102. doi: 10.2217/fmb.15.99. Epub 2015 Sep 1. Review.

16.

Favourable SVR12 rates with boceprevir or telaprevir triple therapy in HIV/HCV coinfected patients.

Arends JE, van der Meer JT, Posthouwer D, Kortmann W, Brinkman K, van Assen S, Smit C, van der Valk M, van der Ende M, Schinkel J, Reiss P, Richter C, Hoepelman AI; Stichting HIV Monitoring/Nederlandse Vereniging van HIV Behandelaren Hepatitis Working Group; ATHENA national observational HIV cohort.

Neth J Med. 2015 Aug;73(7):324-30.

17.

Exercise-induced anaemia: a forgotten cause of iron deficiency anaemia in young adults.

Wouthuyzen-Bakker M, van Assen S.

Br J Gen Pract. 2015 May;65(634):268-9. doi: 10.3399/bjgp15X685069. No abstract available.

18.

Role of therapeutic drug monitoring in pulmonary infections: use and potential for expanded use of dried blood spot samples.

Hofman S, Bolhuis MS, Koster RA, Akkerman OW, van Assen S, Stove C, Alffenaar JW.

Bioanalysis. 2015;7(4):481-95. doi: 10.4155/bio.14.318. Review.

PMID:
25747766
19.

Vaccination of patients with autoimmune inflammatory rheumatic diseases.

Westra J, Rondaan C, van Assen S, Bijl M.

Nat Rev Rheumatol. 2015 Mar;11(3):135-45. doi: 10.1038/nrrheum.2014.206. Epub 2014 Dec 9. Review.

PMID:
25486980
20.

Altered cellular and humoral immunity to varicella-zoster virus in patients with autoimmune diseases.

Rondaan C, de Haan A, Horst G, Hempel JC, van Leer C, Bos NA, van Assen S, Bijl M, Westra J.

Arthritis Rheumatol. 2014 Nov;66(11):3122-8. doi: 10.1002/art.38804.

21.

Peginterferon-alfa mono-therapy in the treatment of acute hepatitis C in HIV-infection.

Boesecke C, van Assen S, Stellbrink HJ, Baumgarten A, Ingiliz P, Strassburg CP, Schwarze-Zander C, Wasmuth JC, Hoepelman AI, Rockstroh JK, Arends JE.

J Viral Hepat. 2014 Nov;21(11):780-5. doi: 10.1111/jvh.12272. Epub 2014 Jul 9.

PMID:
25040149
22.

Important issues for perioperative systemic antimicrobial prophylaxis in surgery.

Sinha B, van Assen S, Friedrich AW.

Curr Opin Anaesthesiol. 2014 Aug;27(4):377-81. doi: 10.1097/ACO.0000000000000097. Review.

PMID:
24979069
23.

Rituximab impairs immunoglobulin (Ig)M and IgG (subclass) responses after influenza vaccination in rheumatoid arthritis patients.

Westra J, van Assen S, Wilting KR, Land J, Horst G, de Haan A, Bijl M.

Clin Exp Immunol. 2014 Oct;178(1):40-7. doi: 10.1111/cei.12390.

24.

[Patients from high-risk regions infected with HIV: recognition can prevent serious complications].

Wouthuyzen-Bakker M, Bierman WF, van Assen S.

Ned Tijdschr Geneeskd. 2012;156(44):A5126. Dutch.

PMID:
23114175
25.

Immunization of patients with autoimmune inflammatory rheumatic diseases (the EULAR recommendations).

van Assen S, Bijl M.

Lupus. 2012 Feb;21(2):162-7. doi: 10.1177/0961203311429555. Review.

PMID:
22235048
26.

Pegylated interferon-α monotherapy leads to low response rates in HIV-infected patients with acute hepatitis C.

Arends JE, van Assen S, Stek CJ, Wensing AM, Fransen JH, Schellens IM, Spijkers SN, Mudrikova T, van Baarle D, Sprenger HG, Hoepelman AI.

Antivir Ther. 2011;16(7):979-88. doi: 10.3851/IMP1843.

PMID:
22024513
27.

Cell-mediated immune responses to inactivated trivalent influenza-vaccination are decreased in patients with common variable immunodeficiency.

van Assen S, de Haan A, Holvast A, Horst G, Gorter L, Westra J, Kallenberg CG, Telgt DS, Palache AM, Giezeman KM, Bijl M.

Clin Immunol. 2011 Nov;141(2):161-8. doi: 10.1016/j.clim.2011.07.004. Epub 2011 Jul 30.

PMID:
21889412
28.

Time-measured phylogenies of gag, pol and env sequence data reveal the direction and time interval of HIV-1 transmission.

Rachinger A, Groeneveld PH, van Assen S, Lemey P, Schuitemaker H.

AIDS. 2011 May 15;25(8):1035-9. doi: 10.1097/QAD.0b013e3283467020.

PMID:
21505318
29.

Vaccination of the immune-compromised patients with focus on patients with autoimmune-inflammatory diseases.

Bijl M, Kallenberg CG, van Assen S.

Neth J Med. 2011 Jan;69(1):5-13. Review.

30.

Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases.

van Assen S, Elkayam O, Agmon-Levin N, Cervera R, Doran MF, Dougados M, Emery P, Geborek P, Ioannidis JP, Jayne DR, Kallenberg CG, Müller-Ladner U, Shoenfeld Y, Stojanovich L, Valesini G, Wulffraat NM, Bijl M.

Autoimmun Rev. 2011 Apr;10(6):341-52. doi: 10.1016/j.autrev.2010.12.003. Epub 2010 Dec 20. Review.

PMID:
21182987
31.

EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases.

van Assen S, Agmon-Levin N, Elkayam O, Cervera R, Doran MF, Dougados M, Emery P, Geborek P, Ioannidis JP, Jayne DR, Kallenberg CG, Müller-Ladner U, Shoenfeld Y, Stojanovich L, Valesini G, Wulffraat NM, Bijl M.

Ann Rheum Dis. 2011 Mar;70(3):414-22. doi: 10.1136/ard.2010.137216. Epub 2010 Dec 3.

PMID:
21131643
32.

Diaphragmatic weakness caused by neuroborreliosis.

van Egmond ME, Luijckx GJ, Kramer H, Benne CA, Slebos DJ, van Assen S.

Clin Neurol Neurosurg. 2011 Feb;113(2):153-5. doi: 10.1016/j.clineuro.2010.09.011. Epub 2010 Oct 20. No abstract available.

PMID:
20965650
33.

Neuralgic amyotrophy associated with Bartonella henselae infection.

Stek CJ, van Eijk JJ, Jacobs BC, Enting RH, Sprenger HG, van Alfen N, van Assen S.

J Neurol Neurosurg Psychiatry. 2011 Jun;82(6):707-8. doi: 10.1136/jnnp.2009.191940. Epub 2010 Aug 14. No abstract available.

PMID:
20710009
34.

Patients with humoral primary immunodeficiency do not develop protective anti-influenza antibody titers after vaccination with trivalent subunit influenza vaccine.

van Assen S, Holvast A, Telgt DS, Benne CA, de Haan A, Westra J, Kallenberg CG, Bijl M.

Clin Immunol. 2010 Aug;136(2):228-35. doi: 10.1016/j.clim.2010.03.430. Epub 2010 Apr 24.

PMID:
20421178
35.

Intravenous voriconazole after toxic oral administration.

Alffenaar JW, van Assen S, de Monchy JG, Uges DR, Kosterink JG, van der Werf TS.

Antimicrob Agents Chemother. 2010 Jun;54(6):2741-2. doi: 10.1128/AAC.01193-09. Epub 2010 Apr 12.

36.

Results of a retrospective database analysis of drug utilization and costs for treatment of chronic hepatitis B virus infection in the northern Netherlands between 2000 and 2006.

Tu HA, Bos JH, Woerdenbag HJ, Visser ST, Wilschut JC, van Assen S, de Jong-van den Berg LT, Postma MJ.

Clin Ther. 2010 Jan;32(1):133-44. doi: 10.1016/j.clinthera.2010.01.015.

PMID:
20171419
37.

Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab.

van Assen S, Holvast A, Benne CA, Posthumus MD, van Leeuwen MA, Voskuyl AE, Blom M, Risselada AP, de Haan A, Westra J, Kallenberg CG, Bijl M.

Arthritis Rheum. 2010 Jan;62(1):75-81. doi: 10.1002/art.25033.

38.

Activated dormant Cryptococcus gattii infection in a Dutch tourist who visited Vancouver Island (Canada): a molecular epidemiological approach.

Hagen F, van Assen S, Luijckx GJ, Boekhout T, Kampinga GA.

Med Mycol. 2010 May;48(3):528-31. doi: 10.3109/13693780903300319.

PMID:
19824880
39.

Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study.

Holvast A, van Assen S, de Haan A, Huckriede A, Benne CA, Westra J, Palache A, Wilschut J, Kallenberg CG, Bijl M.

Rheumatology (Oxford). 2009 Oct;48(10):1294-9. doi: 10.1093/rheumatology/kep200. Epub 2009 Aug 19.

PMID:
19692457
40.

Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus.

Holvast A, van Assen S, de Haan A, Huckriede A, Benne CA, Westra J, Palache A, Wilschut J, Kallenberg CG, Bijl M.

Arthritis Rheum. 2009 Aug;60(8):2438-47. doi: 10.1002/art.24679.

41.

Cell-mediated immune responses to influenza vaccination in Wegener's granulomatosis.

Holvast A, de Haan A, van Assen S, Stegeman CA, Huitema MG, Huckriede A, Benne CA, Westra J, Palache A, Wilschut J, Kallenberg CG, Bijl M.

Ann Rheum Dis. 2010 May;69(5):924-7. doi: 10.1136/ard.2009.112813. Epub 2009 Jul 12.

PMID:
19596692
42.

Omeprazole significantly reduces posaconazole serum trough level.

Alffenaar JW, van Assen S, van der Werf TS, Kosterink JG, Uges DR.

Clin Infect Dis. 2009 Mar 15;48(6):839. doi: 10.1086/597110. No abstract available.

PMID:
19220151
43.

Recovery of viremic control after superinfection with pathogenic HIV type 1 in a long-term elite controller of HIV type 1 infection.

Rachinger A, Navis M, van Assen S, Groeneveld PH, Schuitemaker H.

Clin Infect Dis. 2008 Dec 1;47(11):e86-9. doi: 10.1086/592978.

PMID:
18947331
44.

Rhodococcus equi infection after alemtuzumab therapy for T-cell prolymphocytic leukemia.

Meeuse JJ, Sprenger HG, van Assen S, Leduc D, Daenen SM, Arends JP, van der Werf TS.

Emerg Infect Dis. 2007 Dec;13(12):1942-3. doi: 10.3201/eid1312.061559.

45.

Bilateral renal aspergillosis in a patient with AIDS: a case report and review of reported cases.

Oosten AW, Sprenger HG, van Leeuwen JT, Meessen NE, van Assen S.

AIDS Patient Care STDS. 2008 Jan;22(1):1-6. Review.

PMID:
18095836
46.

Vascular graft infection due to chronic Q fever diagnosed with fusion positron emission tomography/computed tomography.

van Assen S, Houwerzijl EJ, van den Dungen JJ, Koopmans KP.

J Vasc Surg. 2007 Aug;46(2):372. No abstract available.

47.

Positive blood culture with Plasmodium falciparum: case report.

de Vries JJ, van Assen S, Mulder AB, Kampinga GA.

Am J Trop Med Hyg. 2007 Jun;76(6):1098-9.

PMID:
17556617
48.

Return of meningeal symptoms in a patient treated for cryptococcal meningitis.

Huits RM, Bremmer R, Enting RH, Sprenger HG, van Assen S.

J Neurol. 2007 Oct;254(10):1443-4. Epub 2007 Apr 2. No abstract available.

49.

Prevotella bivia necrobacillosis following infectious mononucleosis.

Huits RM, van Assen S, Wildeboer-Veloo AC, Verschuuren EA, Koeter GH.

J Infect. 2006 Aug;53(2):e59-63. Epub 2005 Nov 28.

PMID:
16316686
50.

[Bruises, loose teeth and fatigue in a patient with schizophrenia].

de Boer J, Kalk WW, van Assen S, van der Wouden EJ.

Ned Tijdschr Geneeskd. 2005 Aug 6;149(32):1769-72. Dutch.

PMID:
16121659

Supplemental Content

Loading ...
Support Center